Monika StęPińska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Monika StęPińska has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Alicja Maciejewska
Independent Public Health Care Complex in Pruszków, Pruszków, Poland
10 shared publications - Emilia Lenkiewicz
National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland
10 shared publications - Jakub Winiarczyk
Independent Public Health Care Complex in Pruszków, Pruszków, Poland
10 shared publications - Karolina Dąbrowska
Wojewódzki Szpital w Łomży, Łomża, Poland
10 shared publications - Maja Kaczor
National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland
10 shared publications - Marta Omiecińska
Międzyleski Specialist Hospital of Warsaw, Warsaw, Poland
10 shared publications
Latest Publications
- 24 June 2026
- Published by European Scientific Society in Archiv Euromedica
- Vol. 16 (3)
ARTIFICIAL INTELLIGENCE IN MEDICINE: SUPPORTIVE TOOL OR SOURCE OF NEW CLINICAL RISKS? EVIDENCE FROM POLISH MEDICAL INTERNS AND RESIDENT PHYSICIANS
The growing use of artificial intelligence (AI) in healthcare raises questions about its potential impact on physicians' work, particularly among early-career physicians who are entering the profession during the initial stages of AI implementation in clinical practice. Aims The study aimed to evaluate the perceived impact of artificial intelligence on physicians' work among medical interns and resident physicians in three areas: concerns regarding employment and future medical specializations, perceived usefulness of AI in daily clinical practice, and the impact of AI on physician–patient communication. Methods In February 2026, an anonymous cross-sectional online survey was conducted among medical interns and resident physicians in Poland. Participants were recruited using convenience and snowball sampling. Sixty valid questionnaires were included in the analysis. Descriptive statistics were used to summarize respondents' characteristics and survey responses. Associations between selected variables were assessed using Spearman's rank correlation and Kendall's tau. Differences between paired Likert scale responses were examined using the Wilcoxon signed-rank test. K-means cluster analysis was applied as an exploratory method to identify preliminary response profiles. Because of the small sample size and non-probability sampling, the findings should be interpreted as preliminary and cannot be generalized to the broader population of physicians. Results Sixty valid questionnaires were analyzed. The sample consisted mainly of women (78.33%), medical interns (78.33%), and respondents aged 25 to 30 years (96.67%). Only 8.33% of respondents agreed that the wider use of AI could reduce job opportunities in their specialty, and 6.67% expressed concern that they might be replaced by AI. Most respondents perceived AI as a supportive tool: 80.00% agreed that AI would support them in their future specialty, and 73.33% agreed that it would assist with administrative tasks. At the same time, 26.67% expressed concern about possible medical errors resulting from excessive reliance on AI-generated recommendations, and 63.33% were concerned that patients may question physicians' professional decisions after consulting AI-generated medical information. K-means cluster analysis was used as an exploratory method and identified three preliminary response profiles, differing mainly in concerns about AI-related medical errors and about patients questioning physicians' decisions after using AI-generated information. Conclusions Early-career physicians generally perceive AI as a supportive tool rather than a direct threat to employment. Nevertheless, concerns remain regarding overreliance on AI and potential changes in physician–patient relationships.
- 24 June 2026
- Published by European Scientific Society in Archiv Euromedica
- Vol. 16 (3)
ARTIFICIAL INTELLIGENCE IN MEDICINE: SUPPORTIVE TOOL OR SOURCE OF NEW CLINICAL RISKS? EVIDENCE FROM POLISH MEDICAL INTERNS AND RESIDENT PHYSICIANS
The growing use of artificial intelligence (AI) in healthcare raises questions about its potential impact on physicians' work, particularly among early-career physicians who are entering the profession during the initial stages of AI implementation in clinical practice. Aims The study aimed to evaluate the perceived impact of artificial intelligence on physicians' work among medical interns and resident physicians in three areas: concerns regarding employment and future medical specializations, perceived usefulness of AI in daily clinical practice, and the impact of AI on physician–patient communication. Methods In February 2026, an anonymous cross-sectional online survey was conducted among medical interns and resident physicians in Poland. Participants were recruited using convenience and snowball sampling. Sixty valid questionnaires were included in the analysis. Descriptive statistics were used to summarize respondents' characteristics and survey responses. Associations between selected variables were assessed using Spearman's rank correlation and Kendall's tau. Differences between paired Likert scale responses were examined using the Wilcoxon signed-rank test. K-means cluster analysis was applied as an exploratory method to identify preliminary response profiles. Because of the small sample size and non-probability sampling, the findings should be interpreted as preliminary and cannot be generalized to the broader population of physicians. Results Sixty valid questionnaires were analyzed. The sample consisted mainly of women (78.33%), medical interns (78.33%), and respondents aged 25 to 30 years (96.67%). Only 8.33% of respondents agreed that the wider use of AI could reduce job opportunities in their specialty, and 6.67% expressed concern that they might be replaced by AI. Most respondents perceived AI as a supportive tool: 80.00% agreed that AI would support them in their future specialty, and 73.33% agreed that it would assist with administrative tasks. At the same time, 26.67% expressed concern about possible medical errors resulting from excessive reliance on AI-generated recommendations, and 63.33% were concerned that patients may question physicians' professional decisions after consulting AI-generated medical information. K-means cluster analysis was used as an exploratory method and identified three preliminary response profiles, differing mainly in concerns about AI-related medical errors and about patients questioning physicians' decisions after using AI-generated information. Conclusions Early-career physicians generally perceive AI as a supportive tool rather than a direct threat to employment. Nevertheless, concerns remain regarding overreliance on AI and potential changes in physician–patient relationships.
- Open Access
- 26 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (2(50))
POLISH AND AMERICAN GUIDELINES FOR VITAMIN D DEFICIENCY PREVENTION AND TREATMENT FOR THE GENERAL POPULATION - A LITERATURE REVIEW
Vitamin D plays a well-known role in calcium and phosphate homeostasis. Recent findings also indicate many extraskeletal effects. Studies have shown that a vitamin D deficiency has been associated with chronic conditions in musculoskeletal, cardiovascular, neurological and immune systems. There have been multiple national and international guidelines considering the problem of vitamin D supplementation and treatment. Recommendations for vitamin D prophylaxis and treatment show variability which may result in confusion in clinical practice. The aim of this review is to compare diagnostic thresholds of scrum 25(OH)D levels and dosing strategies for prevention and treatment between selected vitamin D guidelines published in Poland, Central Europe and the United States of America. Future recommendations should integrate the results of observational studies and randomized control trials. This way they may benefit the clinicians and patients by simplifying treatment decisions and improving clinical outcomes.
- 26 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (2(50))
Open AccessPOLISH AND AMERICAN GUIDELINES FOR VITAMIN D DEFICIENCY PREVENTION AND TREATMENT FOR THE GENERAL POPULATION - A LITERATURE REVIEW
Vitamin D plays a well-known role in calcium and phosphate homeostasis. Recent findings also indicate many extraskeletal effects. Studies have shown that a vitamin D deficiency has been associated with chronic conditions in musculoskeletal, cardiovascular, neurological and immune systems. There have been multiple national and international guidelines considering the problem of vitamin D supplementation and treatment. Recommendations for vitamin D prophylaxis and treatment show variability which may result in confusion in clinical practice. The aim of this review is to compare diagnostic thresholds of scrum 25(OH)D levels and dosing strategies for prevention and treatment between selected vitamin D guidelines published in Poland, Central Europe and the United States of America. Future recommendations should integrate the results of observational studies and randomized control trials. This way they may benefit the clinicians and patients by simplifying treatment decisions and improving clinical outcomes.
- Open Access
- 12 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
ARTIFICIAL INTELLIGENCE IN HEALTHCARE: DIAGNOSTIC SUPPORT AND ADMINISTRATIVE AUTOMATION
Background: Artificial intelligence (AI) is rapidly moving from theoretical research into daily hospital operations. While AI promises to improve diagnostic speed and reduce administrative burnout, its real-world success depends on how well it integrates into complex clinical workflows. This review evaluates the practical impact of both discriminative and generative AI on modern healthcare delivery. Methods: We conducted a targeted literature search using PubMed and Semantic Scholar (via Consensus AI) for research published between January 2018 and March 2026. We structured this work as a critical narrative review to focus specifically on the practical challenges and successes of AI in real-world hospital settings. After screening for clinical relevance and the presence of deployment data, we selected 21 peer-reviewed articles for final inclusion. Results: The evidence shows that discriminative AI significantly improves speed in acute care, particularly in sepsis forecasting and stroke triage. Newer models are also showing success in evaluating surgical risks from ECGs and tracking traumatic brain injuries. However, these tools often face challenges like "alert fatigue" and data bias. On the administrative side, generative AI—such as ambient clinical scribes—is successfully reducing documentation time and improving billing accuracy. We found that the success of these tools depends on "Human-in-the-Loop" models and mathematical explainability frameworks, like SHAP values, which help doctors understand and trust AI decisions. Conclusion: AI is becoming a necessary requirement for modern medicine, not just an optional upgrade. By offloading high-volume data tasks to machines, AI can help return the physician’s focus to direct patient care. Future success depends on using protocols that ensure algorithmic transparency and prevent automation bias, ensuring the doctor remains the final authority in clinical decisions.
- 12 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
Open AccessARTIFICIAL INTELLIGENCE IN HEALTHCARE: DIAGNOSTIC SUPPORT AND ADMINISTRATIVE AUTOMATION
Background: Artificial intelligence (AI) is rapidly moving from theoretical research into daily hospital operations. While AI promises to improve diagnostic speed and reduce administrative burnout, its real-world success depends on how well it integrates into complex clinical workflows. This review evaluates the practical impact of both discriminative and generative AI on modern healthcare delivery. Methods: We conducted a targeted literature search using PubMed and Semantic Scholar (via Consensus AI) for research published between January 2018 and March 2026. We structured this work as a critical narrative review to focus specifically on the practical challenges and successes of AI in real-world hospital settings. After screening for clinical relevance and the presence of deployment data, we selected 21 peer-reviewed articles for final inclusion. Results: The evidence shows that discriminative AI significantly improves speed in acute care, particularly in sepsis forecasting and stroke triage. Newer models are also showing success in evaluating surgical risks from ECGs and tracking traumatic brain injuries. However, these tools often face challenges like "alert fatigue" and data bias. On the administrative side, generative AI—such as ambient clinical scribes—is successfully reducing documentation time and improving billing accuracy. We found that the success of these tools depends on "Human-in-the-Loop" models and mathematical explainability frameworks, like SHAP values, which help doctors understand and trust AI decisions. Conclusion: AI is becoming a necessary requirement for modern medicine, not just an optional upgrade. By offloading high-volume data tasks to machines, AI can help return the physician’s focus to direct patient care. Future success depends on using protocols that ensure algorithmic transparency and prevent automation bias, ensuring the doctor remains the final authority in clinical decisions.
- Open Access
- 11 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
PHASE-SPECIFIC TRAINING IN EUMENORRHEIC WOMEN: THE ROLE OF MENSTRUAL CYCLE HORMONAL VARIABILITY IN PERFORMANCE AND ADAPTATION: A LITERATURE REVIEW
Background: The menstrual cycle is a fundamental physiological rhythm in eumenorrheic women, driven by fluctuations in estrogen and progesterone. While these hormones influence substrate metabolism and thermoregulation, their actual impact on athletic performance remains debated. Aim: This narrative review aims to evaluate the effects of menstrual cycle phases on acute exercise performance and chronic training adaptations, and to provide evidence-based practical recommendations. Materials and Methods: A comprehensive literature search was conducted across PubMed, Google Scholar, and Scopus databases, covering original research and systematic reviews published between 2005 and 2025. Analysis focused on eumenorrheic athletes with a particular emphasis on studies utilizing biochemical phase verification. Results: Aerobic capacity (VO2max) and running economy remain stable across the cycle. While follicular-phase resistance training may offer superior strength gains in some cohorts, the broader evidence is inconsistent. A significant disconnect exists between physiological capacity and subjective perception, with athletes reporting performance decrements during the late luteal phase due to cycle-related symptoms. Conclusions: Current evidence does not support the universal application of rigid, phase-based training models for eumenorrheic athletes. The high inter-individual variability in cycle characteristics and symptom severity suggests that a generalized approach is insufficient. Instead, practitioners are encouraged to adopt an individualized "symptom-based" monitoring strategy, adjusting training loads in response to specific athlete feedback rather than presumed physiological shifts.
- 11 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
Open AccessPHASE-SPECIFIC TRAINING IN EUMENORRHEIC WOMEN: THE ROLE OF MENSTRUAL CYCLE HORMONAL VARIABILITY IN PERFORMANCE AND ADAPTATION: A LITERATURE REVIEW
Background: The menstrual cycle is a fundamental physiological rhythm in eumenorrheic women, driven by fluctuations in estrogen and progesterone. While these hormones influence substrate metabolism and thermoregulation, their actual impact on athletic performance remains debated. Aim: This narrative review aims to evaluate the effects of menstrual cycle phases on acute exercise performance and chronic training adaptations, and to provide evidence-based practical recommendations. Materials and Methods: A comprehensive literature search was conducted across PubMed, Google Scholar, and Scopus databases, covering original research and systematic reviews published between 2005 and 2025. Analysis focused on eumenorrheic athletes with a particular emphasis on studies utilizing biochemical phase verification. Results: Aerobic capacity (VO2max) and running economy remain stable across the cycle. While follicular-phase resistance training may offer superior strength gains in some cohorts, the broader evidence is inconsistent. A significant disconnect exists between physiological capacity and subjective perception, with athletes reporting performance decrements during the late luteal phase due to cycle-related symptoms. Conclusions: Current evidence does not support the universal application of rigid, phase-based training models for eumenorrheic athletes. The high inter-individual variability in cycle characteristics and symptom severity suggests that a generalized approach is insufficient. Instead, practitioners are encouraged to adopt an individualized "symptom-based" monitoring strategy, adjusting training loads in response to specific athlete feedback rather than presumed physiological shifts.
- Open Access
- 4 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
THE RISE OF DIGITAL SELF-DIAGNOSIS: TECHNOLOGICAL INNOVATION AND ITS SOCIAL AND HEALTHCARE SYSTEM IMPLICATIONS
The rapid expansion of digital health technologies has transformed how people seek, interpret, and use medical information. Tools supporting self-diagnosis—such as online symptom checkers, AI-based chatbots, wearable biosensors, and mobile health applications—are now widely used across healthcare systems. This review examines the clinical, ethical, and societal implications of these developments. A structured search of PubMed/MEDLINE, Google Scholar, and the Cochrane Library identified peer-reviewed studies published between 2010 and 2025 evaluating consumer-oriented diagnostic technologies. Eligible studies addressed diagnostic performance, behavioral outcomes, regulation, health literacy, and equity. Due to methodological heterogeneity, results were synthesized narratively. Evidence suggests that digital self-diagnosis tools provide several benefits, including improved access to health information, earlier symptom assessment, triage support, and greater patient engagement. These advantages may be particularly important in resource-limited settings and during periods of healthcare system strain. However, notable concerns remain. Diagnostic accuracy varies considerably, and triage advice may be overly cautious or occasionally inappropriate. Additional risks include increased health anxiety, exposure to misinformation, data privacy issues, and the potential to exacerbate existing social inequalities. Moreover, the current evidence base is uneven, with limited real-world validation and insufficient research on long-term behavioral and professional impacts. Digital self-diagnosis represents a lasting structural change rather than a temporary trend. Its effective integration into healthcare systems will require stronger regulatory oversight, greater investment in digital health literacy, and interdisciplinary research addressing clinical effectiveness, ethical governance, and equity. Careful management is necessary to ensure that technological innovation strengthens—rather than undermines—the quality and fairness of medical care.
- 4 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
Open AccessTHE RISE OF DIGITAL SELF-DIAGNOSIS: TECHNOLOGICAL INNOVATION AND ITS SOCIAL AND HEALTHCARE SYSTEM IMPLICATIONS
The rapid expansion of digital health technologies has transformed how people seek, interpret, and use medical information. Tools supporting self-diagnosis—such as online symptom checkers, AI-based chatbots, wearable biosensors, and mobile health applications—are now widely used across healthcare systems. This review examines the clinical, ethical, and societal implications of these developments. A structured search of PubMed/MEDLINE, Google Scholar, and the Cochrane Library identified peer-reviewed studies published between 2010 and 2025 evaluating consumer-oriented diagnostic technologies. Eligible studies addressed diagnostic performance, behavioral outcomes, regulation, health literacy, and equity. Due to methodological heterogeneity, results were synthesized narratively. Evidence suggests that digital self-diagnosis tools provide several benefits, including improved access to health information, earlier symptom assessment, triage support, and greater patient engagement. These advantages may be particularly important in resource-limited settings and during periods of healthcare system strain. However, notable concerns remain. Diagnostic accuracy varies considerably, and triage advice may be overly cautious or occasionally inappropriate. Additional risks include increased health anxiety, exposure to misinformation, data privacy issues, and the potential to exacerbate existing social inequalities. Moreover, the current evidence base is uneven, with limited real-world validation and insufficient research on long-term behavioral and professional impacts. Digital self-diagnosis represents a lasting structural change rather than a temporary trend. Its effective integration into healthcare systems will require stronger regulatory oversight, greater investment in digital health literacy, and interdisciplinary research addressing clinical effectiveness, ethical governance, and equity. Careful management is necessary to ensure that technological innovation strengthens—rather than undermines—the quality and fairness of medical care.
- Open Access
- 30 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
MEMORY-SUPPORT TECHNOLOGIES IN THE AGE OF ARTIFICIAL INTELLIGENCE: COGNITIVE OFFLOADING, SOCIETAL IMPLICATIONS, AND CONDITIONS FOR RESPONSIBLE IMPLEMENTATION
Research objective: This integrative review examines the impact of memory-aided technology on the encoding, storage, retrieval, and coordination of everyday activities and shared information practices: smartphone reminders, cloud storage, wearable lifelogs, clinical cognitive prostheses, and AI personal assistants, as well as the implications that exist at both the individual and institutional levels. Methodology: An integrative review was conducted by synthesizing evidence across disciplines including Cognitive Psychology, Human-Computer Interaction, Neuro-Rehabilitation, Governance of Artificial Intelligence, and Digital Rights. The data were then organized using a Taxonomy of Evidence-Informed Technology Families. Findings: Externalizing memory has been found to have numerous benefits, including decreasing cognitive load, improving performance, and increasing independence. However, there are also trade-offs associated with externalizing memory, such as the shift towards "where-to-find" encoding, the potential for altered metacognitive calibration, decreased effort, attentional costs, or dependence on the device. Societal Findings: These types of devices have also enabled coordination, continuity, and accountability; however, they also pose risks to users' privacy and consent, the use of biased algorithms, users' autonomy, and equal access to these devices. Conclusion: To responsibly deploy memory-aided technology will require designers to create user-centered and clinically grounded products, evaluate them over time to determine their effects beyond accuracy, incorporate privacy-by-design principles into the development process, create transparent and auditable pipelines for artificial intelligence systems, plan for future compatibility and continuity, provide users with training and support services, and develop regulatory frameworks and standards that protect users' rights.
- 30 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
Open AccessMEMORY-SUPPORT TECHNOLOGIES IN THE AGE OF ARTIFICIAL INTELLIGENCE: COGNITIVE OFFLOADING, SOCIETAL IMPLICATIONS, AND CONDITIONS FOR RESPONSIBLE IMPLEMENTATION
Research objective: This integrative review examines the impact of memory-aided technology on the encoding, storage, retrieval, and coordination of everyday activities and shared information practices: smartphone reminders, cloud storage, wearable lifelogs, clinical cognitive prostheses, and AI personal assistants, as well as the implications that exist at both the individual and institutional levels. Methodology: An integrative review was conducted by synthesizing evidence across disciplines including Cognitive Psychology, Human-Computer Interaction, Neuro-Rehabilitation, Governance of Artificial Intelligence, and Digital Rights. The data were then organized using a Taxonomy of Evidence-Informed Technology Families. Findings: Externalizing memory has been found to have numerous benefits, including decreasing cognitive load, improving performance, and increasing independence. However, there are also trade-offs associated with externalizing memory, such as the shift towards "where-to-find" encoding, the potential for altered metacognitive calibration, decreased effort, attentional costs, or dependence on the device. Societal Findings: These types of devices have also enabled coordination, continuity, and accountability; however, they also pose risks to users' privacy and consent, the use of biased algorithms, users' autonomy, and equal access to these devices. Conclusion: To responsibly deploy memory-aided technology will require designers to create user-centered and clinically grounded products, evaluate them over time to determine their effects beyond accuracy, incorporate privacy-by-design principles into the development process, create transparent and auditable pipelines for artificial intelligence systems, plan for future compatibility and continuity, provide users with training and support services, and develop regulatory frameworks and standards that protect users' rights.
- Open Access
- 30 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
DIGITAL INTERVENTIONS IN PSYCHODERMATOLOGY: NAVIGATING MENTAL HEALTH RISKS AND SOCIAL ISOLATION IN ACNE VULGARIS
Background: Acne vulgaris is a chronic dermatological disease that, beyond its visible cutaneous manifestations, exerts a significant negative impact on psychological well-being. Clinical evidence demonstrates that the persistent nature of this inflammatory condition is directly associated with a heightened susceptibility to clinical depression, anxiety, and body dysmorphic disorder (BDD). This inherent link between skin health and mental state necessitates a comprehensive, integrated approach to patient care. Objective: This narrative review first aims to illuminate the profound psychological dimensions of acne vulgaris—particularly the emotional distress and social isolation experienced by patients. Subsequently, it critically evaluates the role of modern digital health interventions (mHealth, teledermatology, artificial intelligence) in managing this burden and analyzes the dual impact of social media on patients' psychosocial functioning. Methods: A systematic literature search was conducted across primary scientific databases, leading to the selection of 23 peer-reviewed articles. The incorporated studies specifically focused on the psychiatric toll of inflammatory skin diseases, the clinical efficacy of remote care, and the societal implications of emerging digital phenomena in dermatology. Results and Discussion: The synthesized evidence indicates that structured digital tools—most notably internet-delivered cognitive behavioral therapy (ICBT) and mobile applications grounded in self-regulation theory—effectively improve clinical outcomes while restoring patients’ sense of personal control over their condition. Furthermore, while the diagnostic accuracy of artificial intelligence (AI) models continues to evolve, their integration introduces a standardized, data-driven assessment. This emotionless baseline can assist patients in rationalizing their distorted self-image. However, the modern social media landscape exerts a distinctly paradoxical influence. While grassroots initiatives like the "acne positivity" movement actively combat social isolation by fostering peer-support networks, these platforms simultaneously expose vulnerable users to unrealistic aesthetic standards that can exacerbate dysmorphic symptoms. Additionally, this environment is frequently saturated with unverified medical information, predominantly driven by influencers promoting pseudoscientific therapies. Conclusions: To optimize psychodermatological care, healthcare systems must adopt hybrid ("blended care") treatment models that seamlessly integrate traditional in-person consultations with remote digital monitoring, thereby preserving the fundamental physician-patient relationship. Furthermore, the industry requires stricter regulatory oversight of commercial medical applications. It is equally critical to train diagnostic AI algorithms on highly diverse datasets encompassing all skin phototypes to prevent algorithmic bias. Finally, the medical community must establish a proactive online presence to actively counter digital misinformation.
- 30 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
Open AccessDIGITAL INTERVENTIONS IN PSYCHODERMATOLOGY: NAVIGATING MENTAL HEALTH RISKS AND SOCIAL ISOLATION IN ACNE VULGARIS
Background: Acne vulgaris is a chronic dermatological disease that, beyond its visible cutaneous manifestations, exerts a significant negative impact on psychological well-being. Clinical evidence demonstrates that the persistent nature of this inflammatory condition is directly associated with a heightened susceptibility to clinical depression, anxiety, and body dysmorphic disorder (BDD). This inherent link between skin health and mental state necessitates a comprehensive, integrated approach to patient care. Objective: This narrative review first aims to illuminate the profound psychological dimensions of acne vulgaris—particularly the emotional distress and social isolation experienced by patients. Subsequently, it critically evaluates the role of modern digital health interventions (mHealth, teledermatology, artificial intelligence) in managing this burden and analyzes the dual impact of social media on patients' psychosocial functioning. Methods: A systematic literature search was conducted across primary scientific databases, leading to the selection of 23 peer-reviewed articles. The incorporated studies specifically focused on the psychiatric toll of inflammatory skin diseases, the clinical efficacy of remote care, and the societal implications of emerging digital phenomena in dermatology. Results and Discussion: The synthesized evidence indicates that structured digital tools—most notably internet-delivered cognitive behavioral therapy (ICBT) and mobile applications grounded in self-regulation theory—effectively improve clinical outcomes while restoring patients’ sense of personal control over their condition. Furthermore, while the diagnostic accuracy of artificial intelligence (AI) models continues to evolve, their integration introduces a standardized, data-driven assessment. This emotionless baseline can assist patients in rationalizing their distorted self-image. However, the modern social media landscape exerts a distinctly paradoxical influence. While grassroots initiatives like the "acne positivity" movement actively combat social isolation by fostering peer-support networks, these platforms simultaneously expose vulnerable users to unrealistic aesthetic standards that can exacerbate dysmorphic symptoms. Additionally, this environment is frequently saturated with unverified medical information, predominantly driven by influencers promoting pseudoscientific therapies. Conclusions: To optimize psychodermatological care, healthcare systems must adopt hybrid ("blended care") treatment models that seamlessly integrate traditional in-person consultations with remote digital monitoring, thereby preserving the fundamental physician-patient relationship. Furthermore, the industry requires stricter regulatory oversight of commercial medical applications. It is equally critical to train diagnostic AI algorithms on highly diverse datasets encompassing all skin phototypes to prevent algorithmic bias. Finally, the medical community must establish a proactive online presence to actively counter digital misinformation.
- Open Access
- 30 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
ENDOMETRIOSIS AND THYROID DYSFUNCTION: EPIDEMIOLOGICAL EVIDENCE, THYROID AUTOIMMUNITY, AND TSH-T3/T4 AXIS MECHANISMS IN ENDOMETRIOSIS PATHOPHYSIOLOGY
Background: Endometriosis is a chronic inflammatory gynecological condition characterized by immune dysregulation and a wide range of systemic complications. Thyroid disorders are also common in women of reproductive age and may overlap with endometriosis through shared autoimmune pathways and endocrine signaling. Objective: This review aims to summarize epidemiological and clinical evidence linking endometriosis with thyroid dysfunction and thyroid autoimmunity and to place these findings in the context of mechanistic research on the TSH–T3/T4 axis. Methods: Researchers searched for original studies reporting both diagnosed endometriosis and thyroid-related outcomes, including thyroid disorders, autoimmune thyroiditis, thyroid autoantibodies, TSH receptor antibodies, and thyroid neoplasms. The evidence was synthesized narratively. Results: Large EHR- and claims-based studies generally reported increased risks of hypothyroidism, hyperthyroidism, Graves’ disease, thyroiditis, goiter, and thyroid neoplasms after an endometriosis diagnosis. Clinical and biomarker studies were more variable: one case–control cohort found comparable rates of thyroid dysfunction and anti-thyroid antibodies in cases and controls, whereas other cohorts reported a higher prevalence of autoimmune thyroiditis, lower free T4 levels, associations between anti-thyroid peroxidase antibody levels and endometrioma size, and a higher prevalence of Hashimoto thyroiditis in an IVF/ICSI population. In one diagnostic biomarker study, adding anti-thyroid peroxidase and thyroglobulin antibodies to CA125 improved discrimination between ovarian endometriomas and other benign ovarian tumors (AUC 0.924). Studies of TRAb suggested elevated titers in some cohorts, but this finding was not reproduced with routine clinical TRAb assays, underscoring assay dependence. Mechanistic studies support biological plausibility by showing altered thyroid hormone metabolism in endometriotic tissue and proliferative, pro-oxidative effects of TSH, T3, and T4. Conclusions: Overall, the literature points to an association between endometriosis and thyroid-related outcomes; however, substantial heterogeneity and potential bias make it difficult to translate these findings into clear screening recommendations. Future research should prioritize standardized phenotyping, harmonized antibody testing, and prospective studies linking clinical thyroid status with the biology of endometriosis.
- 30 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
Open AccessENDOMETRIOSIS AND THYROID DYSFUNCTION: EPIDEMIOLOGICAL EVIDENCE, THYROID AUTOIMMUNITY, AND TSH-T3/T4 AXIS MECHANISMS IN ENDOMETRIOSIS PATHOPHYSIOLOGY
Background: Endometriosis is a chronic inflammatory gynecological condition characterized by immune dysregulation and a wide range of systemic complications. Thyroid disorders are also common in women of reproductive age and may overlap with endometriosis through shared autoimmune pathways and endocrine signaling. Objective: This review aims to summarize epidemiological and clinical evidence linking endometriosis with thyroid dysfunction and thyroid autoimmunity and to place these findings in the context of mechanistic research on the TSH–T3/T4 axis. Methods: Researchers searched for original studies reporting both diagnosed endometriosis and thyroid-related outcomes, including thyroid disorders, autoimmune thyroiditis, thyroid autoantibodies, TSH receptor antibodies, and thyroid neoplasms. The evidence was synthesized narratively. Results: Large EHR- and claims-based studies generally reported increased risks of hypothyroidism, hyperthyroidism, Graves’ disease, thyroiditis, goiter, and thyroid neoplasms after an endometriosis diagnosis. Clinical and biomarker studies were more variable: one case–control cohort found comparable rates of thyroid dysfunction and anti-thyroid antibodies in cases and controls, whereas other cohorts reported a higher prevalence of autoimmune thyroiditis, lower free T4 levels, associations between anti-thyroid peroxidase antibody levels and endometrioma size, and a higher prevalence of Hashimoto thyroiditis in an IVF/ICSI population. In one diagnostic biomarker study, adding anti-thyroid peroxidase and thyroglobulin antibodies to CA125 improved discrimination between ovarian endometriomas and other benign ovarian tumors (AUC 0.924). Studies of TRAb suggested elevated titers in some cohorts, but this finding was not reproduced with routine clinical TRAb assays, underscoring assay dependence. Mechanistic studies support biological plausibility by showing altered thyroid hormone metabolism in endometriotic tissue and proliferative, pro-oxidative effects of TSH, T3, and T4. Conclusions: Overall, the literature points to an association between endometriosis and thyroid-related outcomes; however, substantial heterogeneity and potential bias make it difficult to translate these findings into clear screening recommendations. Future research should prioritize standardized phenotyping, harmonized antibody testing, and prospective studies linking clinical thyroid status with the biology of endometriosis.
- Open Access
- 28 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
THE ROLE OF SMALL INTESTINAL BACTERIAL OVERGROWTH IN THE PATHOGENESIS, MANAGEMENT AND QUALITY OF LIFE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME – A LITERATURE REVIEW
Background: Small intestinal bacterial overgrowth (SIBO) contributes significantly to the pathogenesis and symptom severity of irritable bowel syndrome (IBS). It is associated with microbial dysbiosis, abnormal intestinal gas fermentation, altered motility, and systemic metabolic and neurocognitive effects, including brain fogginess. Diagnostic uncertainty and lack of a universally accepted gold standard complicate clinical management. Aim: This review synthesizes current evidence on disease mechanisms, diagnostic challenges, therapeutic strategies, and the impact on patient quality of life in SIBO-associated IBS. Methods: A literature search was conducted in PubMed, Scopus, and Google Scholar for full-text articles published between 2000 and 2025. Clinical studies, systematic reviews, and meta-analyses addressing pathophysiology, diagnostics, and treatment outcomes were included. Results: Microbial dysbiosis exacerbates gastrointestinal symptoms through excessive gas production and disrupted motility. Patients frequently report cognitive impairments, including brain fogginess, alongside gastrointestinal distress. Targeted therapy with nonabsorbable antibiotics provides significant symptom relief and improves functional capacity. Persistent diagnostic challenges underscore the need for standardized breath testing and microbial assessments to guide management. Conclusion: Incorporating specific microbial diagnostics into routine gastroenterological practice is essential for optimizing treatment in SIBO-associated IBS. Recognizing the multifaceted impact of bacterial overgrowth enables clinicians to implement targeted therapies, address both intestinal and systemic consequences, and improve long-term patient outcomes.
- 28 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
Open AccessTHE ROLE OF SMALL INTESTINAL BACTERIAL OVERGROWTH IN THE PATHOGENESIS, MANAGEMENT AND QUALITY OF LIFE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME – A LITERATURE REVIEW
Background: Small intestinal bacterial overgrowth (SIBO) contributes significantly to the pathogenesis and symptom severity of irritable bowel syndrome (IBS). It is associated with microbial dysbiosis, abnormal intestinal gas fermentation, altered motility, and systemic metabolic and neurocognitive effects, including brain fogginess. Diagnostic uncertainty and lack of a universally accepted gold standard complicate clinical management. Aim: This review synthesizes current evidence on disease mechanisms, diagnostic challenges, therapeutic strategies, and the impact on patient quality of life in SIBO-associated IBS. Methods: A literature search was conducted in PubMed, Scopus, and Google Scholar for full-text articles published between 2000 and 2025. Clinical studies, systematic reviews, and meta-analyses addressing pathophysiology, diagnostics, and treatment outcomes were included. Results: Microbial dysbiosis exacerbates gastrointestinal symptoms through excessive gas production and disrupted motility. Patients frequently report cognitive impairments, including brain fogginess, alongside gastrointestinal distress. Targeted therapy with nonabsorbable antibiotics provides significant symptom relief and improves functional capacity. Persistent diagnostic challenges underscore the need for standardized breath testing and microbial assessments to guide management. Conclusion: Incorporating specific microbial diagnostics into routine gastroenterological practice is essential for optimizing treatment in SIBO-associated IBS. Recognizing the multifaceted impact of bacterial overgrowth enables clinicians to implement targeted therapies, address both intestinal and systemic consequences, and improve long-term patient outcomes.
- Open Access
- 23 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
BERBERINE IN METABOLIC DISORDERS: THE “NATURE’S OZEMPIC” PHENOMENON - A NARRATIVE REVIEW
Background: Metabolic disorders, particularly type 2 diabetes and obesity, represent one of the greatest public health challenges of the 21st century. In response to the limitations and side effects of conventional pharmacotherapy, many patients are seeking natural alternatives. Berberine, a traditional medicinal plant compound, has become increasingly popular on social media under the label “Nature’s Ozempic.” Objective: This narrative review provides a comprehensive synthesis of berberine in metabolic disorders. It examines its molecular mechanisms, clinical evidence, safety profile, pharmacological interactions, and the public health consequences of its rapid rise on social media. Methods: A targeted literature search was conducted in PubMed, Scopus, Web of Science, and Google Scholar. Priority was given to randomised controlled trials, meta-analyses, mechanistic studies, and recent publications analysing social media trends. The articles published between 2009 and 2026 were primarily included. Main Findings: Berberine acts through multiple pathways, most notably AMPK activation, modulation of the gut microbiota, and anti-inflammatory effects. Clinical studies show mild but consistent improvements in glycemic control, insulin sensitivity, and lipid parameters, particularly in patients with type 2 diabetes or metabolic syndrome. Its impact on body weight and visceral fat is generally limited. Short-term safety is acceptable, with mainly mild gastrointestinal side effects, although potential interactions with cytochrome P450 enzymes and P-glycoprotein have been documented. Conclusions: Berberine may serve as a useful adjunctive option in selected patients, but it cannot replace standard therapies such as metformin or statins. Its growing popularity on social media has encouraged widespread self-medication, raising concerns about safety and unrealistic expectations. Larger, longer-term, and more diverse studies are needed to define its true clinical value and long-term safety.
- 23 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
Open AccessBERBERINE IN METABOLIC DISORDERS: THE “NATURE’S OZEMPIC” PHENOMENON - A NARRATIVE REVIEW
Background: Metabolic disorders, particularly type 2 diabetes and obesity, represent one of the greatest public health challenges of the 21st century. In response to the limitations and side effects of conventional pharmacotherapy, many patients are seeking natural alternatives. Berberine, a traditional medicinal plant compound, has become increasingly popular on social media under the label “Nature’s Ozempic.” Objective: This narrative review provides a comprehensive synthesis of berberine in metabolic disorders. It examines its molecular mechanisms, clinical evidence, safety profile, pharmacological interactions, and the public health consequences of its rapid rise on social media. Methods: A targeted literature search was conducted in PubMed, Scopus, Web of Science, and Google Scholar. Priority was given to randomised controlled trials, meta-analyses, mechanistic studies, and recent publications analysing social media trends. The articles published between 2009 and 2026 were primarily included. Main Findings: Berberine acts through multiple pathways, most notably AMPK activation, modulation of the gut microbiota, and anti-inflammatory effects. Clinical studies show mild but consistent improvements in glycemic control, insulin sensitivity, and lipid parameters, particularly in patients with type 2 diabetes or metabolic syndrome. Its impact on body weight and visceral fat is generally limited. Short-term safety is acceptable, with mainly mild gastrointestinal side effects, although potential interactions with cytochrome P450 enzymes and P-glycoprotein have been documented. Conclusions: Berberine may serve as a useful adjunctive option in selected patients, but it cannot replace standard therapies such as metformin or statins. Its growing popularity on social media has encouraged widespread self-medication, raising concerns about safety and unrealistic expectations. Larger, longer-term, and more diverse studies are needed to define its true clinical value and long-term safety.